Developer of an AI-driven cancer biology platform designed to predict how therapies will perform in patients. Genialis is based in Boston, MA. Its last reported valuation was $37 million in Jan 2023. It has raised $16.4 million across 2 recorded rounds; the latest was a $700,000 seed round in Dec 2025.
Last reported valuation
$37.0M
Oct 2026
Priced at
—
Total raised
$16.4M
Last round
Seed Round
Dec 2025
Team — not yet on record
No current team members for Genialis are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Genialis with a free account
·Watch Genialis: the Monday email on marks, rounds and moves
